MikeAllanRoyalMD

Anesthesiology • San Diego, CA

Pain Medicine

Physician

Join to view full profile

Dr. Royal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Royal's full profile

Already have an account?

Office
12481 High Bluff Dr
Ste 200
San Diego, CA 92130
Phone+1 858-436-1427

Fax+1 858-436-1401

Education & Training

Allegheny Health Network Medical Education Consortium (AGH/WPH)Residency, Anesthesiology, 1990 - 1992
National Capital ConsortiumResidency, Internal Medicine, 1981 - 1984
University of Massachusetts Medical SchoolClass of 1981

Certifications & Licensure

FL State Medical License 2024 - 2027
CA State Medical License 2003 - 2026
NC State Medical License 2017 - 2020
PA State Medical License 1988 - 2006
OK State Medical License 1994 - 2003
MD State Medical License 1984 - 1991
American Board of Anesthesiology Anesthesiology
American Board of Internal Medicine Internal Medicine

Clinical Trials

Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery Start of enrollment: 2006 Nov 01
Completed
Phase 3

Publications & Presentations

PubMed

190 citations
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.
Dennis C Turk, Robert H Dworkin, Robert R Allen, Nicholas Bellamy, Nancy Brandenburg
Pain. 2003-12-01
227 citations
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations
Dennis C. Turk, Robert H. Dworkin, Laurie B. Burke, Richard Gershon, Rothman Ml
Pain. 2006-12-05
25 citations
A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever.
W. Frank Peacock, James B. Breitmeyer, Christine Pan, William B. Smith, Mike A. Royal
Academic Emergency Medicine. 2011-04-01

Press Mentions

Sorrento Therapeutics Inc. (NASDAQ: SRNE) Releases Preliminary Phase 2 Abivertinib Study Results for Hospitalized COVID-19 PatientsNovember 9th, 2021
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Releases Preliminary Phase 2 Abivertinib Study Results for Hospitalized COVID-19 PatientsNovember 9th, 2021
San Diego Therapeutics Company Battles COVID-19 VariantsMarch 9th, 2021
Join now to see all